Northern California Cancer Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1984
NCT00427310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1989

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4